Binimetinib trials for Melanoma

All Binimetinib trials · All Melanoma trials

Phase breakdown

Recruiting trials studying Binimetinib for Melanoma

• A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
  NCT04511013 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 331 locations
• A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
  NCT05355701 · Phase: Phase 1 · Ages: 16 Years and older · Sex: All (male and female) · 40 locations
• Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
  NCT04045691 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 59 locations
• Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
  NCT05026983 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
  NCT04598009 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Melanoma Metastasized to the Brain and Steroids
  NCT03563729 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
  NCT04903119 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
  NCT03947385 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations

Common questions

How many trials study Binimetinib for Melanoma?

8 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.